HER2 as a prognostic and predictive marker for breast cancer

By Cooke T.   Reeves J.   Lanigan A.   Stanton P.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer

By Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 979-995

Springer Publishing Company

Access to resources Recommend Favorite

Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph nodenegative early breast cancer: 15-year follow-up

By                

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1777-1787

Spandidos Publications

Access to resources Recommend Favorite

FOXA1 is an independent prognostic marker for ER-positive breast cancer

By Mehta Rutika  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 881-890

Springer Publishing Company

Access to resources Recommend Favorite

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy

By Patel Akshar  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite